Source: https://www.prarulebook.co.uk/pra-rules/disclosure-crr/01-01-2027?p=1 · captured 2026-09-28 · checked 2026-09-28 · e50731f3

1601(b) For the disclosures required in points (f), (g), (k), and (m) of Article 439(1) of CRR, in accordance with the Template UKB CCR1 of Annex XXV and the relevant instructions set out in Annex XXVI.
1602
1603(c) [Deleted]
1604
1605(d) For the disclosures required in point (l) of Article 439(1) of CRR, in accordance with the Templates UKB CCR3 and UK CCR4 of Annex XXV and the relevant instructions set out in Annex XXVI.
1606
1607(e) For the disclosures required in point (e) of Article 439(1) of CRR, in accordance with the Template UK CCR5 of Annex XXV and the relevant instructions set out in Annex XXVI.
1608
1609(f) For the disclosures required in point (j) of Article 439(1) of CRR, in accordance with the Template UK CCR6 of Annex XXV and the relevant instructions set out in Annex XXVI.
1610
1611(g) For the disclosures required in point (h) of Article 438 of CRR, for Internal Model Method, in accordance with the Template UK CCR7 of Annex XXV and the relevant instructions set out in Annex XXVI.
1612
1613(h) For the disclosures required in point (i) of 439(1) of CRR, in accordance with the Template UK CCR8 of Annex XXV and the relevant instructions set out in Annex XXVI.
1614
161501/01/2027
1616
1617Article 14a Disclosure of Exposures to CVA Risk
1618
16191.
1620
1621Institutions shall disclose the information on CVA risk required in point (a) of Article 435(1) and points (a) and (b) of Article 439a(1), in accordance with Template UKB CVAA of Annex XXXIX and the relevant instructions set out in Annex XXXX.
1622
162301/01/2027
1624
16252.
1626
1627Institutions using the reduced version of the BA-CVA shall disclose the information on CVA risk required in point (c) of Article 439a(1), in accordance with Template UKB CVA1 of Annex XXXIX and the relevant instructions set out in Annex XXXX.
1628
162901/01/2027
1630
16313.
1632
1633Institutions using the full version of the BA-CVA shall disclose the information on CVA risk required in point (c) of Article 439a(1), in accordance with Template UKB CVA2 of Annex XXXIX and the relevant instructions set out in Annex XXXX.
1634
163501/01/2027
1636
16374.
1638
1639Institutions using SA-CVA shall disclose the information on CVA risk required in point (d) of Article 439a(1), as follows:
1640
1641(a) For the disclosures required in point (b) of Article 435(1) and (d)(i) of Article 439a(1), in accordance with Template UKB CVAB of Annex XXXIX and the relevant instructions set out in Annex XXXX;
1642
1643(b) For the disclosures required in point (c) of Article 439a(1), in accordance with Template UKB CVA3 of Annex XXXIX and the relevant instructions set out in Annex XXXX;
1644
1645(c) For the disclosures required in point (d)(ii) of Article 439a(1), in accordance with Template UKB CVA4 of Annex XXXIX and the relevant instructions set out in Annex XXXX.
1646
164701/01/2027
1648
1649Article 15 Disclosure of Exposures to Securitisation Positions
1650
1651Institutions shall make the disclosures on the exposures to securitisation positions required in Article 449 of the CRR as follows:
1652
1653(a) For the disclosures required in points (a) to (i) of Article 449 of the CRR, in accordance with the Table UK-SECA of Annex XXVII and the relevant instructions set out in Annex XXVIII.
1654
1655(b) For the disclosures required in point (j) of Article 449 of the CRR, in accordance with the Templates UK-SEC1 and UK-SEC2 of Annex XXVII and the relevant instructions set out in Annex XXVIII.
1656
1657(c) For the disclosures required in point (k) of Article 449 of the CRR in accordance with the Templates UK-SEC3 and UK-SEC4 of Annex XXVII and the relevant instructions set out in Annex XXVIII.
1658
1659(d) For the disclosures required in point (l) of Article 449 of the CRR in accordance with the Templates UK-SEC5 of Annex XXVII and the relevant instructions set out in Annex XXVIII.
1660
166101/01/2022
1662
1663Article 16 Disclosure of Use of Standardised Approach and Internal Model for Market Risk
1664
16651.
1666
1667Institutions shall make the disclosures required in point (b) of Article 445(1) and points (a) to (d) of Article 435(1) of CRR regarding market risk in accordance with the Template UKB MRA of Annex XXIX and the relevant instructions set out in Annex XXX.
1668
166901/01/2027
1670
16712.
1672
1673Institutions shall make the disclosures required in Articles 445 and 455 of CRR as follows:
1674
1675(a) For the disclosures required in point (a) of Article 445(1), in accordance with Template UKB MR1 of Annex XXIX and the relevant instructions set out in Annex XXX.
1676
1677(b) For the disclosures required in point (b) of Article 445(1), in accordance with Template UKB MR3 of Annex XXIX and the relevant instructions set out in Annex XXX.
1678
1679(c) For the disclosures required in points (a), (b) and (c) of Article 455(1), in accordance with the Template UKB MRB of Annex XXIX and the relevant instructions set out in Annex XXX.
1680
1681(d) For the disclosures required in points (d) to (g) of Article 455(1), in accordance with Template UKB MR2 of Annex XXIX and the relevant instructions set out in Annex XXX.
1682
1683(e) [Deleted]
1684
1685(f) [Deleted]
1686
168701/01/2027
1688
1689Article 17 Disclosure of Operational Risk
1690
16911.
1692
1693Institutions shall disclose the information on operational risk required in Article 435 of CRR in accordance with the Table UKB ORA of Annex XXXI and the relevant instructions set out in Annex XXXII.
1694
169501/01/2027
1696
16972.
1698
1699Institutions with a Business Indicator equal to or greater than GBP 880 million shall disclose the information on operational risk loss data required in paragraph 1 of Article 446, in accordance with Template UKB OR1 of Annex XXXI and the relevant instructions set out in Annex XXXII.
1700